Andrew James Hotchen

Andrew James Hotchen

Auto-generated profile, based on publicly available information

Andrew James Hotchen

Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2023 in Bone & Joint Research
Verified
Journal Article
Open access
PDF file
JFJamie Ferguson
Jamie Ferguson
JBJonathan Bourget-Murray
Jonathan Bourget-Murray
DSDavid Stubbs
David Stubbs
MMMartin A McNally
Martin A McNally
AHAndrew J. Hotchen
Andrew J. Hotchen
Aims: Dead-space management, following dead bone resection, is an important element of successful chronic osteomyelitis treatment. This study compared two different biodegradable antibiotic carriers used for dead-space management, and reviewed clinical and radiological outcomes. All cases underwent single-stage surgery and had a minimum one-year follow-up.Methods: A total of 179 patients received preformed calcium sulphate pellets containing 4% tobramycin (Group OT), and 180 patients had an injectable calcium sulphate/nanocrystalline hydroxyapatite ceramic containing gentamicin (Group CG). Outcome measures were infection recurrence, wound leakage, and subsequent fracture involving the treated segment. Bone-void filling was assessed radiologically at a minimum of six months post-surgery.Results: The median follow-up was 4.6 years (interquartile range (IQR) 3.2 to 5.4; range 1.3 to 10.5) in Group OT compared to 4.9 years (IQR 2.1 to 6.0; range 1.0 to 8.3) in Group CG. The groups had similar defect sizes following excision (both mean 10.9 cm3 (1 to 30)). Infection recurrence was higher in Group OT (20/179 (11.2%) vs 8/180 (4.4%), p = 0.019) than Group CG, as was early wound leakage (33/179 (18.4%) vs 18/180 (10.0%), p = 0.024) and subsequent fracture (11/179 (6.1%) vs 1.7% (3/180), p = 0.032). Group OT cases had an odds ratio 2.9-times higher of developing any one of these complications, compared to Group CG (95% confidence interval 1.74 to 4.81, p < 0.001). The mean bone-void healing in Group CG was better than in Group OT, in those with ≥ six-month radiological follow-up (73.9% vs 40.0%, p < 0.001).Conclusion: Local antibiotic carrier choice affects outcome in chronic osteomyelitis surgery. A biphasic injectable carrier with a slower dissolution time was associated with better radiological and clinical outcomes compared to a preformed calcium sulphate pellet carrier.Cite this article: Bone Joint Res 2023;12(7):412–422.

6 November 2021 in eClinicalMedicine
Verified
Journal Article
Open access
AHAndrew James Hotchen
Andrew James Hotchen
MWMartina Galea Wismayer
Martina Galea Wismayer
EREve Robertson-Waters
Eve Robertson-Waters
SMStephen M. McDonnell
Stephen M. McDonnell
BKBen Kendrick
Ben Kendrick
MMMartin A McNally
Martin A McNally
There is currently no commonly accepted method of stratifying complexity of prosthetic joint infection (PJI). This study assesses a new classification, the Joint-Specific, Bone involvement, Anti-microbial options, Coverage of the soft tissues, Host status (JS-BACH) classification, for predicting clinical and patient reported outcomes in PJI. Patients who received surgery for PJI at two centres in the UK between 2010 and 2015 were classified using JS-BACH as ‘uncomplicated’, ‘complex’ or ‘limited treatment options’. Patient reported outcomes were recorded at 365-days following the index operation and included the EuroQol EQ-5D-3L index score and the EQ-visual analogue score (VAS). Clinical outcome data were obtained from the most recent follow-up appointment. 220 patients met the inclusion criteria. At 365-days following the index operation, patients with ‘uncomplicated’ PJI reported similar EQ-index scores (0.730, SD:0.326) and EQ-VAS (79.4, SD:20.9) compared to the age-matched population. Scores for ‘uncomplicated’ PJI were significantly higher than patients classified as having ‘complex’ (EQ-index:0.515 SD:0.323, p = 0.012; EQ-VAS:68.4 SD:19.4, p = 0.042) and ‘limited treatment options’ PJI (EQ-index:0.333 SD:0.383, p < 0.001; EQ-VAS:60.2, SD:23.1, p = 0.005). The median time to final follow-up was 4.7 years (inter-quartile range 2.7–6.7 years) where there were 74 cases (33.6%) of confirmed recurrence. Using death as a competing risk, the Cox proportional-hazards ratio of recurrence for ‘complex’ versus ‘uncomplicated’ PJI was 23.7 (95% CI:3.23–174.0, p = 0.002) and having ‘limited options’ verses ‘uncomplicated’ PJI was 57.7 (95% CI:7.66–433.9, p < 0.001). The JS-BACH classification can help predict likelihood of recurrence and quality of life following surgery for PJI. This will aid clinicians in sharing prognostic information with patients and help guide referral for specialist management of PJI.

3 June 2018 in The Journal of Knee Surgery
Verified
Journal Article
Closed access
PDF file
AHAndrew J. Hotchen
Andrew J. Hotchen
CDCharis Demetriou
Charis Demetriou
DEDennis Edwards
Dennis Edwards
JMJoel T. K. Melton
Joel T. K. Melton
The presentation and clinical course of mucoid degeneration of the anterior cruciate ligament (MD-ACL) are poorly documented within the literature. Subsequently, it is under-diagnosed and the optimal management strategy remains ill-defined. Here, we characterize the syndrome associated with MD-ACL and compare the natural clinical course with the outcomes of arthroscopic management. Thirty-one patients with radiological features of MD-ACL over a 2-year period had their clinical notes retrospectively reviewed. Seven patients underwent arthroscopic debridement of the ACL for MD. These were followed up for a minimum of 2 years and an average of 2.8 years from surgery. The remainder were managed conservatively (n = 24) and were followed up for a minimum of 2 years and an average of 4.0 years. The notch width index (NWI) and associated pathology was noted. Primary outcome measures were presence of knee pain and use of analgesia. Secondary outcome measures were the Oxford and Lysholm knee scores. The most commonly reported symptoms were posterior knee pain (77.4%) and limitation of terminal flexion (58.1%). All patients who underwent arthroscopic debridement were pain and analgesia free at follow-up. Of the patients who did not undergo arthroscopic surgery, three patients had knee replacement surgery and three were lost to follow-up. The remaining patients, 14/18 (77.8%), reported knee pain and regular analgesia use at follow-up, which was significantly more than the arthroscopic debridement group (p < 0.01). The knee scores were significantly better in the arthroscopic debridement group at follow-up (Oxford knee score: 45 vs 34; Lysholm: 92 vs 67; p < 0.01). Furthermore, the postoperative improvement in the Oxford knee and Lysholm scores compared with preoperatively was 12.1 and 31.8 points, respectively (p < 0.01). The NWI was increased in patients with mild-to-severe osteoarthritis (0.266 vs 0.273; p < 0.05). MD-ACL should be considered in patients who report posterior knee pain, limitation of terminal flexion, and it can be associated with other knee pathologies. MD-ACL can be successfully managed with arthroscopic radio frequency debulking with improvement in quality of life at follow-up. Ethical approval was sought and granted by the local research and development committee in our hospital.

1 April 2021 in Bone & Joint Open
Verified
Journal Article
Open access
AHAndrew James Hotchen
Andrew James Hotchen
SKSaad A. Khan
Saad A. Khan
MKMaaz A. Khan
Maaz A. Khan
MSMatthew Seah
Matthew Seah
ZCZain H. Charface
Zain H. Charface
SMStephen M. McDonnell
Stephen M. McDonnell
Aims: To investigate factors that contribute to patient decisions regarding attendance for arthroplasty during the COVID-19 pandemic.Methods: A postal questionnaire was distributed to patients on the waiting list for hip or knee arthroplasty in a single tertiary centre within the UK. Patient factors that may have influenced the decision to attend for arthroplasty, global quality of life (QoL) (EuroQol five-dimension three-level (EQ-5D-3L)), and joint-specific QoL (Oxford Hip or Knee Score) were assessed. Patients were asked at which ‘COVID-alert’ level they would be willing to attend an NHS and a “COVID-light” hospital for arthroplasty. Independent predictors were assessed using multivariate logistic regression.Results: Of 540 distributed questionnaires, 400 (74.1%; 236 awaiting hip arthroplasty, 164 awaiting knee arthroplasty) complete responses were received and included. Less than half (48.2%) were willing to attend for hip or knee arthroplasty while a UK COVID-19 epidemic was in circulation (COVID-alert levels 3 to 5). Patients with worse joint-specific QoL had a preference to proceed with surgery at COVID-alert levels 3 to 5 compared to levels 1 and 2 (hip arthroplasty odds ratio (OR) 1.54 (95% confidence interval (CI) 1.45 to 1.63); knee arthroplasty OR 1.16 (1.07 to 1.26)). The odds of patients with worse joint-specific QoL being willing to attend for surgery at COVID-alert levels 3 to 5 increased further if surgery in a private, “COVID-light” hospital was available (hip arthroplasty OR 3.50 (95% CI 3.26 to 3.71); knee arthroplasty OR 1.41 (95% CI 1.29 to 1.53).Conclusion: Patient decisions surrounding elective surgery have been influenced by the global COVID-19 pandemic, highlighting the importance of patient involvement in ensuring optimized provision of elective surgery during these challenging times. Cite this article: Bone Jt Open 2021;2(4):261–270.

9 April 2018 in Arthroscopy Techniques
Verified
Journal Article
Open access
AHAndrew J. Hotchen
Andrew J. Hotchen
JMJoel T.K. Melton
Joel T.K. Melton
Mucoid degeneration of the anterior cruciate ligament (MD‐ACL) is an underdiagnosed ACL pathology. When recognized, one potential management strategy involves arthroscopic debridement to “debulk” the ACL. Here, with the addition of video footage, we describe our arthroscopic technique for MD‐ACL debridement using radiofrequency ablation. We show the engorged, stranded MD‐ACL during arthroscopy and how this engorgement causes impingement in the femoral notch, resulting in the symptoms described by the patient. After radiofrequency ablation, we show a reduction in impingement and assess the stability of the cruciate ligaments. This Technical Note aims to raise awareness of this pathology and show the technique of arthroscopic radiofrequency ablation to reduce impingement of the ACL within the femoral notch. Technique Video: video See video under supplementary data.